A team of researchers has found an association between breast cancer survival and two proteins that, when present in the blood in high levels, are indicators of inflammation. Using data from the Health, Eating, Activity and Lifestyle (HEAL) study sponsored by the National Cancer Institute, part of the National Institutes of Health, the researchers found that breast cancer patients with elevated levels of C-reactive protein (CRP) and serum amyloid A (SAA) were approximately two to three times more likely to die sooner or have their cancer return than those patients who had lower levels of these proteins, regardless of the patient's age, tumour stage, race, body mass index, or history of previous cardiovascular issues. The results of this study were published online 26 May in the Journal of Clinical Oncology...
- Researchers identify biological markers that may indicate poor breast cancer prognosisTue, 26 May 2009, 16:37:46 EDT
- C-reactive protein levels predict breast cancer survival ratesFri, 3 Jun 2011, 3:07:54 EDT
- Markers for inflammation discovered in breast cancer survivors are linked to survivalTue, 26 May 2009, 16:37:54 EDT
- Researchers find possible clues to tamoxifen resistance in breast cancer patientsWed, 30 Mar 2011, 17:02:52 EDT
- Level of tumor protein indicates chances cancer will spreadTue, 1 Feb 2011, 12:39:05 EST